A report – Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including Mycobacterium tuberculosis – launched on Tuesday by the World Health Organization (WHO) shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.
Next week, 2-3 December, senior government representatives from more than 30 countries are expected to agree on a pilot system for collecting data on antibiotic resistance—a major step forward in addressing this threat to global public health.